|
|
Article: Grunenthal GmBH Selects invivodata for International Pain Program.(Clinical report)
- Article from:
- Business Wire
- Article date:
- August 6, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Successful Results from Previous Studies Fuel Decision
PITTSBURGH -- invivodata([R]) inc., the industry leader in electronic patient reported outcomes (ePRO) solutions for global clinical research, today announced that Grunenthal GmBH has selected DiaryPRO([R]), invivodata's field-based ePRO system, for an international, four-study pain program.
Grunenthal is undertaking this extensive clinical development program to evaluate the safety and efficacy of a new chemical entity in several pain indications. During the program, nearly 3,500 patients throughout eastern and western Europe will use DiaryPRO to record the frequency and severity of pain as it ...